Recombinant TIA1 anticorps
Aperçu rapide pour Recombinant TIA1 anticorps (ABIN7882488)
Antigène
Voir toutes TIA1 AnticorpsType d'anticorp
Reactivité
Hôte
Clonalité
Conjugué
Application
Classe de qualité
Clone
-
-
Fonction
- Recombinant TIA-1 Antibody / T-Cell Intracellular Antigen-1 (azide and preservative free)
-
Purification
- Protein A affinity
-
Immunogène
- Human bone marrow malignant cells from a non B, non T acute leukemia were used as the immunogen for the recombinant TIA-1 antibody.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal dilution of the recombinant TIA-1 antibody should be determined by the researcher.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- 1 mg/mL in 1X PBS, BSA free, sodium azide free
-
Agent conservateur
- Azide free
-
Stock
- -20 °C
-
Stockage commentaire
- Aliquot the recombinant TIA-1 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
-
-
- TIA1 (TIA1 Cytotoxic Granule-Associated RNA Binding Protein (TIA1))
-
Autre désignation
- TIA-1
-
Sujet
- The T cell intracellular antigen 1 (TIA 1) is a 17 kDa cytoplasmic granule associated protein also designated as GMP 17, for granule membrane protein of 17 kDa. The GMP 17/TIA 1 Molecule is expressed in cells possessing cytolytic potential and could be involved in the signaling cascade of Fas (CD95) mediated apoptosis. Within hematopoietic cell lines, the TIA1/1352R monoclonal antibody reacts with about 90 % of CD16+, 50 60 % of CD8+, and less than 10 % of CD4+ normal peripheral blood lymphocytes. It reacts with almost all monocytes and granulocytes. This antibody also reacts with CD4+ activated T cell clones, activated NK cell clones, and Con activated thymocytes, but not with B lymphocytes or B cell lines. TIA1 antibody labels cytotoxic T cells and natural killer cells (NK cells). It is also expressed in T-cell lymphoma, large granular lymphocyte (LGL) leukemia and hairy cell leukemia. TIA1 expression in T-cell malignancies may help in differentiating LGL leukemia (high expression) from T-cell lymphocytosis and other T-cell diseases (low expression). TIA1 may also be used to label tumor-infiltrating lymphocytes in the study of immune response to malignancies.
-
UniProt
- P31483
Antigène
-